Wednesday, January 12, 2022

US FDA News: Buprenorphine: Drug Safety Communication - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

FDA is warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth.
Read more: Buprenorphine: Drug Safety Communication - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain